SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study is to determine whether RADIOEMBOLIZATION with 90 Yttrium microspheres is more effective on overall survival in advanced Hepatocellular carcinoma (HCC) with or without portal venous obstruction and no extrahepatic extension than sorafenib which is now the standard treatment of advanced HCC.
Epistemonikos ID: 4de548adffdb65e7f4a7abeef7cd470cea7cd8e1
First added on: May 10, 2024